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MIGIS: High Performance Spatial Query System for Analytical Pathology Imaging

**Ablimit Aji^1^, Qiaoling Liu^1^, Fusheng Wang^2,3^, Tahsin Kurç^2,3^, Joel Saltz^2,3^**

^1^Department of Mathematics and Computer Science, Emory University, Atlanta, GA, ^2^Department of Biomedical Informatics, Emory University, Atlanta, GA, ^3^Center for Comprehensive Informatics, Emory University, Atlanta, GA. E-mail: <aaji@mathcs@emory.edu>

**CONTENT**

Systematic analysis of large-scale microscopy images can generate tremendous amount of spatially derived quantifications for micro-anatomic objects such as nuclei and blood vessels. Most queries on the results are spatially oriented, highly computational, and data intensive. For example, there are queries on spatial cross-matching of multiple sets of segmented objects and on spatial proximity between micro-anatomic objects and local neighbor density. We report our recent progress on developing a highly scalable and efficient query system for supporting large-scale analytical queries on pathology images.

**TECHNOLOGY**

We are developing a MapReduce-based framework MIGIS to support cost-effective high performance spatial queries on commodity clusters. The data are staged on Hadoop distributed file system (HDFS) which supports reliable storage with replication. We are building a spatial query engine by extending CGAL computational geometry library and spatial index library. We will take advantage of the open source MapReduce framework Hadoop for parallelizing and scheduling query execution.

**DESIGN**

MIGIS consists of a spatial query engine RESQUE which runs spatial query by building spatial indexes on the fly. Data files with segmented boundaries and extracted spatial features are merged and staged onto HDFS. Spatial queries are expressed as "map" and "reduce" functions and parallel execution is performed by Hadoop. Effective job optimization is performed to minimize query execution bottleneck due to data skew on MapReduce.

**RESULTS**

MIGIS supports following queries: spatial cross-matching query for algorithm evaluation, nearest neighbor queries to find closest blood vessel for each cell, and high-density queries to find regions with high concentration of nuclei, such as pseudopalisades. We tested our experimental study with datasets of 18 and 50 whole slide images, respectively. Our study demonstrates high scalability of the queries on MapReduce.

**CONCLUSION**

The big data from medical imaging---the vast amount of spatially derived information generated from pathology image analysis---shares similar requirements for high performance and scalability with enterprise data, but in a unique way. Our system MIGIS demonstrates an effective and highly scalable solution that can run on cost-effective commodity clusters. This can be used for algorithm sensitivity study and whole slide image analysis.

Evaluation of 655 Patent Applications Related to Digital Pathology

**Ioan C. Cucoranu^1^, Anil V. Parwani^1^, Ronald Weinstein^2^, Jonhan Ho^1^, Liron Pantanowitz^1^**

^1^Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, ^2^University of Arizona, Tucson, AZ. E-mail: <cucoranuic@upmc.edu>

**CONTENT**

Digital pathology is reshaping the practice of pathology. Development of applications for telepathology and image analysis will play a major role in the future adoption of digital pathology. There have been major technological advances in this field over the last two decades. Most of these developments have been captured in the form of patents, to protect the intellectual property of inventors. Our aim was to systematically evaluate patents related to digital pathology.

**TECHNOLOGY**

Patents published in databases at [www.uspto.gov](www.uspto.gov) (United States Patent and Trademark Office, Alexandria, Virginia, USA), were searched using Google Patents (Google Inc., Mountain View, California, USA). Data were extracted and analyzed with Papers software (Mekentosj BV, Aalsmeer, Netherlands).

**DESIGN**

The United States Patent and Trademark Office public database was queried using the following keywords: "Computer assisted diagnosis and pathology," "digital image analysis and pathology," "digital imaging and pathology," "digital imaging and pathology and data security," "digital microscopy," "digital pathology," "telemicroscopy," "telepathology," "telepathology and data security," "videomicroscopy," "virtual microscopy," "virtual pathology," "whole slide imaging," "whole slide scanner and pathology." Google search engine was used to facilitate the download of data into the Papers application.

**RESULTS**

A total of 655 patent applications related to the field of digital pathology were identified, including 413 (63%) patents specific to pathology use, and 242 (37%) patents also usable beyond pathology. Of the 413 pathology specific filed patents, 297 (72%) were awarded and 63 of them expired (due to non-payment of maintenance fees or term end). There were also 52 abandoned applications, 63 pending patents, and 1 rejected application. Several (28) initial telepathology patents were related to television. The number of pathology-specific patent applications quadrupled in the last decade: 68 (1991-2000) versus 323 (2001-2010). The number of patents actually awarded almost tripled during these periods \[[Figure 1](#F1){ref-type="fig"}\]: 66 versus 208.
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**CONCLUSION**

This study shows that there have been many patent applications related to digital pathology in the last two decades. Of these, the number of patents specific to use in pathology almost quadrupled in the last decade. Most (2/3) of them are related to telepathology (including whole slide imaging, data management, networking, data security, and user interface), whereas the rest (1/3) are related to image analysis. Based on these observations, technological advances related to digital pathology, especially tools for image analysis are expected to increase in the future.

Early Experience with Optical Coherence Tomography: A Novel 3D Imaging Modality in Pathology

**Jeffrey L. Fine, Ioan Cucoranu**

Department of Pathology, University of Pittsburgh, Pittsburgh, PA. E-mail: <finejl@upmc.edu>

**CONTENT**

Optical coherence tomography (OCT) and related three-dimensional (3D) microscopy techniques can potentially allow pathologic diagnosis directly from tissue, without glass microscope slides. Our early efforts have focused on correlation with histopathology and optimizing the imaging process, first with an ophthalmic system and now with a newer pathology system. We present our experience with OCT imaging as we begin systematic studies with the technique.

**TECHNOLOGY**

Modified full-field OCT (Light CT, LLTech, Paris, France), using a motorized stage to capture and stitch together multiple ×10 fields of view into a single image or image stack. Its resolution is about 1 *μ*m (transversely and axially). Resulting images are viewed using included software. H and E slides were scanned using a WSI system (Aperio XT, Vista, California, USA).

**DESIGN**

Fixed and fresh tissue was scanned using several different imaging parameters. H and E slides from the imaged tissue were subsequently prepared and compared. In addition to evaluating images for diagnostic features, scans were evaluated for other features such as depth into tissue, scan time, and usefulness of quality parameters.

**RESULTS**

Tissue samples from 22 patients (about 50 tissue samples) were scanned. Large-area images were limited to one (or few) focal planes into the tissue, but thicker 3D image stacks were possible using fewer fields of view. Resolution appears adequate to discern small features (fat septa in breast, recognizably mucinous glands in an ovarian tumor), but images appear to have limited contrast in many tissue types. Both fixed and fresh tissue worked well, though there appear to be subtle differences in image quality related to firmness of fixed tissue.

**CONCLUSION**

OCT is an exciting imaging modality and many histopathologic features are recognizable in our images. Further studies are needed to better establish its utility in clinical settings such as "room temperature" frozen section, or even *in-vivo* imaging. Image size, capture speed, and other technical issues exist but will likely be solved with hardware improvements if a market for clinical applications develops. Other medical specialties are already developing 3D microscopy applications, and if pathologists can become involved, we will be better able to adapt as future medical diagnostic work evolves.

A Method for Quantitative Analysis of Ki67 with Enlarged Follicles in Follicular Lymphoma

**Bruce Levy^1^, Yukako Yagi^2^, Abner Louissaint Jr.^3^**

^1^Department of Pathology, University of Illinois at Chicago, Chicago, IL, ^2^Pathology Imaging and Communication Technology Lab, Massachusetts General Hospital, Boston, MA, ^3^Department of Pathology, Massachusetts General Hospital, Boston, MA. E-mail: <bplevy@uic.edu>

**CONTENT**

In many cases, the size of an area of interest or image analysis software may restrict simple quantitative analysis. For example, while analyzing cases of follicular lymphoma stained for Ki67, enlarged/coalesced follicles could not be analyzed from a single captured image. A method was developed to subdivide these follicles into smaller segments that were analyzed individually and then mathematically reconstituted to determine Ki67 positivity for the entire follicle.

**TECHNOLOGY**

A Hamamatsu Nanozoomer 2.0 HT scanner with associated scanning and viewing software, ImmunoRatio image analysis software (<http://imtmicroscope.uta.fi/immunoratio/>), and a basic desktop computer and monitor were used in this study.

**DESIGN**

Slides of follicular lymphoma stained with Ki67 were scanned with a Hamamatsu Nanozoomer 2.0 HT scanner with NDP.scan software at ×20 objective magnification. A pathologist examined the slides using NDP.serve viewer and divided the follicles into two-dimensional grids of 0.1 mm^2^ squares that were individually exported. Each square was analyzed for the percentage of Ki67-positive nuclei using ImmunoRatio image analysis software. The pathologist defined the boundaries and determined the area of the follicle in each exported image, and the software calculated the percentage of nuclei positive for Ki67. The average percent positivity for the entire follicle was then calculated utilizing the formula:

Average positivity = Σ(*A~n~*\**P~n~*)/Total area

where *A* is the Area of follicle in each square, *P*, the percent positivity for each square, and *n* is the number of squares making up a follicle.

**RESULTS**

Comparing the analysis of follicles analyzed in their entirety and then divided into between two and four segments validated the method. A total of 23 cases of follicular lymphoma were evaluated using this method. Areas analyzed per case ranged from 1.3519 mm^2^ to 5.1404 mm^2^. The Ki67 positivity was calculated to be between 3.6% and 82.1%.

**CONCLUSION**

The grid method presented in this paper demonstrates a process in which larger areas that cannot be quantitatively analyzed in one image can be broken down and evaluated in a systematic method. It could be automated, providing a quantitative result for an entire slide quickly and reliably. The process is not limited to Ki67 analysis, but could be applied to many different quantitative analyses. It can also be used to compare different areas from the same case for variations in positivity, which was noted in this study, but not further analyzed at this time.
